Specialty Pharmacy Times: May/June

From the Chairman
Market Access in Oncology: Shooting for the Moon
Market access and health care professionals must work to find the balance to provide solid treatment for cancer without burdening the system to a point of collapse.
Viewpoints: The Last Word
Why Is CAR T Therapy the Next Step for Oncology?
CAR T-cell immunotherapy is being hailed as the fifth pillar of cancer treatment.
Should Manufacturers Contract for Oncology Drug Program Coverage?
Although nearly every state has some type of rule governing coverage of oncology drugs, the question that continually pops up is whether these rules matter when it comes to formulary inclusion.
Aiming for Value Over Volume in Cancer Drug Spending
Several groups have developed value assessment frameworks that consider the value of new treatments, yet most models fall short balancing the evaluation of treatment costs with the consideration of benefits to the patient.
Achieve Gold Standard Oral Oncology Drug Adherence Through Collaboration
Health care providers—including physicians, oncologists, and specialty pharmacists—must leverage their collective resources and expertise to work together to address adherence on a larger scale. 
Current and Future Considerations for the Safe Handling of Hazardous Drugs
Current guidelines suggest that a comprehensive safety program is necessary to reduce hazardous drug exposure in the workplace. 
The Role of the Pharmacist as Part of a Multidisciplinary Cancer Care Team
The high-level monitoring required for self-managing patients with cancer becomes a challenge when patients are seen less frequently by their provider.
Oncology Economics
Oncology economics is the product of driving forces in the health insurance market that are intrinsic to oncology in managed care and unlikely to change.
Health-System Perspectives on Oncology Market Access in 2018
There is an ongoing shift toward many cancer types being treated as maintenance diseases, which places a significant financial burden not only on patients, but also payers and providers within the health care industry.
Variations and Nuances in Colorectal Cancer Drug Dosing
Specialty pharmacists need to fully understand capecitabine’s place in colorectal cancer treatment to ensure that it is safely and effectively utilized.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.